Retour à l'accueil - Logo CERMN

EA 4258 | Centre d'études et de recherche sur le médicament de Normandie

Accueil > Production scientifique > Communications orales


Communications orales

Communications orales 2020

O1-2020       
New potent benzisoxazole derivatives as pleiotropic compounds with 5HT4R agonism and in cellulo antioxidant properties to fight Alzheimer’s disease
Lanthier, C., liparulo, I., Payan, H., Lecoutey, C., Since, M., Davis, A., Claeysen, S., Bolognesi, M.L., Dallemagne, P., Rochais, C.
27th Young Research Fellow Meeting , Caen, 29-31 Janvier 2020

O2-2020
Matrix metalloproteinases as new biological targets in Alzheimer’s disease: Opportunities and Challenges
Zipfel, P., Lalut, J., Denis, C., Bureau, R., Suzanne, P., Davis, A., Malzert-Fréon, A., Baranger, K., Khrestchatisky, M., Rivera, S., Rochais, C., Dallemagne, P.
27th Young Research Fellow Meeting , Caen, 29-31 Janvier 2020

O3-2020       
Development of safe and brain-targeting nanovectors for Alzheimer’s disease treatment
Séguy, L., Groo, A.C., Maurel, M., Verdié, P., Dallemagne, P., Lisowski, V., Malzert-Fréon, A.
27th Young Research Fellow Meeting , Caen, 29-31 Janvier 2020

O4-2020       
MR35806: a new fluorinated indazole compound as a potential 5-HT4R PET radiotracer
Mangeant, R., Stiebing, S., Cailly, T., Davis, A., Fabis, F., Collot, V.
27th Young Research Fellow Meeting , Caen, 29-31 Janvier 2020

O5-2020       
Design, synthesis and characterization of small molecules as new Tau aggregation disruptors
Giovannini, J., Jouanne, M., Sopkova-De Oliveira Santos, J., Catto, M., Voisin-Chiret, A.S
27th Young Research Fellow Meeting , Caen, 29-31 Janvier 2020

O6-2020       
Development of TrkB/5-HT4 receptors ligands, a new approach in the treatment of neurodegenerative diseases
Antonijevic, M., Charou, D., Rogdakis, T., Papadopoulou, M., Gravanis, A., Charalampopoulos, I., Dallemagne, P., Rochais, C.
27th Young Research Fellow Meeting , Caen, 29-31 Janvier 2020
Prix de la meilleure communication flash

O7-2020       
In silico design and synthesis of original MT2R/5-HT2CR MTDLs as potential therapeutics for Alzheimer’s disease.
Thirumaran, S.L., Bureau, R., Lepailleur, A., Rochais, C.
27th Young Research Fellow Meeting , Caen, 29-31 Janvier 2020

O8-2020       
Drug repositioning based on real life side effects, identifying unkown butyrylcholinesterase inhibitors useful in alzheimer’s disease treatment
Jourdan, J.P., Chrétien, B., Davis, A., Dolladille, C., Bureau, R., Fedrizzi, S., Lelong-Boulouard, V., Sassier, M., Alexandre, J., Rochais, C., Dallemagne, P.
27th Young Research Fellow Meeting , Caen, 29-31 Janvier 2020

O9-2020       
Design of small protein-protein interaction disruptors to overcome apoptosis resistance
Guedeney, N., Antraygues, K., Jouanne, M., Sopkovà de Oliveira Santos, J., Voisin-Chiret, A.-S., Kieffer, C.
27th Young Research Fellow Meeting , Caen, 29-31 Janvier 2020

O10-2020       
Exploring Brain – Immune interaction with hyper – polarized Xenon – 129 Magnetic Resonance Imaging
Vigier, C., Dubost, E., Vivien, D., Fernandez, C., Cailly, T., Fabis, F.
27th Young Research Fellow Meeting , Caen, 29-31 Janvier 2020

O11-2020       
Synthèse d’inhibiteurs de MT5-MMP
Remondin, C., Rochais, C., Dallemagne, P.
Journées Scientifiques Francophone  du CALM, Montpellier, 17-18 Novembre 2020

O12-2020       
From 3D models of Tau protein aggregates to conception and synthesis of potential Tau aggregation disruptors
Giovannini, J., Jouanne, M., Sopkova-de Oliveira Santos, J., Voisin-Chiret, A.S.
Journées de l'Ecole Doctorale Normande de Chimie, November 26-27 2020

O13-2020       
Exploring Brain –Immune interaction with hyper –polarized Xenon –129 Magnetic Resonance Imaging
Vigier, C., Dubost, E., Vivien, D., Fernandez, C., Cailly, T., Fabis, F.
Journées de l'Ecole Doctorale Normande de Chimie, November 26-27 2020

O14-2020       
Development of innovative nanovectors for targeted brain delivery
Séguy, L.,  Groo, A.C., Guyon, L., Corvaisier, S., Davis, A., Maurel, M., Verdié, P., Dallemagne, P., Lisowski, V., Malzert-Fréon, A.
Journées de l'Ecole Doctorale Normande de Chimie, November 26-27 2020

O15-2020       
Multi-target neurotrophin receptors ligands, an emerging strategyin the treatment of neurodegenerative diseases
Antonijevic, M., Charou, D., Rogdakis, T., Papadopoulou, M., Gravanis, A., Charalampopoulos, I., Dallemagne, P., Rochais, C.
Journées de l'Ecole Doctorale Normande de Chimie, November 26-27 2020
Prix de la meilleure communication orale des JEDNC

O16-2020       
Development of small molecules neurotrophin mimetics, an emerging strategy in the treatment of neurodegenerative disorders
Antonijevic, M., Charou, D., Rogdakis, T., Papadopoulou, M., Gravanis, A., Charalampopoulos, I., Dallemagne, P., Rochais, C.
Drug Discovery Day, Lille, 16 Décembre 2020

Télécharger la page

Dernière modification : 18 mars 2021



Université de Caen Normandie
CERMN Centre détudes et de recherche sur le médicament de Normandie
Boulevard Becquerel | 14032 Caen Cedex | France